Pricing FAQs

The pricing framework distinguishes between the dermatologist consultation — the calibrated clinical visit that produces the assessment and the written plan — and the procedural pathway that may follow. The consultation is priced as a flat fee, currently ₹1,999*, covering the visit time, the clinical assessment, photographic baseline establishment where applicable, blood-work interpretation when applicable, and the written plan that the patient leaves with. Procedural pathways are priced separately per their respective protocols, and the per-pathway figure is calibrated case-by-case at the consultation rather than displayed as a website list price. The asterisk on the consultation fee allows for future revision; the figure quoted at the time of booking applies to that booking.

Procedural pricing for dermatology pathways depends on factors that only the consultation can establish — the case calibration, the realistic session count for the patient's zone and concern, the device selection appropriate to the patient's skin context, and the maintenance pattern that follows the active course. Listing a single figure on a website without that calibration would push the framework toward selling fixed packages that do not fit the case. The framework deliberately avoids price-led routing of patients into pathways that the assessment does not support. The consultation produces the calibrated figure for the patient's actual case.

Yes. The consultation includes the calibrated quote for the recommended pathway based on the actual clinical assessment. The patient leaves the visit with the written plan including the proposed pathway, the realistic session structure, the per-component pricing for that case, and the maintenance pattern thereafter. The pricing is transparent at the consultation rather than discovered piecemeal as the pathway proceeds.

The consultation-stage quote applies to the pathway as discussed; subsequent calibration changes (a different recommended device, a different session count after early-response review, an extended maintenance pattern) are discussed with the patient and agreed before they are added. The framework does not embed surprise charges; calibration changes that affect cost are surfaced and approved rather than billed silently. Specific operational mechanics are covered in the formal Refund, Cancellation and Rescheduling Policy in the policies section.

The asterisk indicates that the figure is subject to periodic revision rather than being a permanent fixed-figure claim. The figure quoted at the point of booking applies to that booking once confirmed. The framework provides clear figures at the booking conversation rather than relying on website text alone for pricing commitments.

The flat ₹1,999* dermatologist consultation fee covers the visit time itself (typically thirty-to-forty-five minutes, longer for complex multi-concern cases), the calibrated clinical assessment, the photographic baseline where the pathway warrants it, blood-work interpretation when applicable, the written plan that the patient leaves with, and the time the dermatologist takes to review prior reports the patient brings to the visit. The fee is for the consultation visit itself rather than as a deposit against subsequent treatment.

The consultation fee is structured as the cost of the consultation rather than as a deposit. Whether the fee is adjustable against subsequent treatment in selected pathways is operationally discussed at the booking conversation and at the consultation; the framework treats the consultation as substantive value-creating in itself rather than as a free-with-purchase entry funnel. Patients who choose not to proceed with the recommended pathway have already received the calibrated assessment and the written plan from the visit.

The visit-stage photographic baseline is covered within the consultation fee. The interpretation of blood-work the patient brings to the visit is similarly part of the consultation work. Where the visit recommends a fresh blood-work panel, the cost of running those tests sits with the laboratory pathway the patient uses; the consultation fee does not cover external laboratory charges. Where the visit recommends additional investigations the routing is discussed at the visit.

Selected online or video consultations are appropriate in defined contexts — initial orientation visits for distance-restricted patients, follow-up reviews where in-person examination is not necessary, and selected coordination visits. The pricing structure for online consultation is discussed at booking rather than as a separate website rate-card; the framework recognises that online visits cannot replace examination-dependent assessments and routes those visits accordingly. The formal Teleconsultation Policy in the policies section covers the operational frame.

Follow-up visit pricing is calibrated to the visit nature — short progress reviews within an active pathway are typically structured differently from full re-assessments after substantial gaps. The framework discusses follow-up pricing at the consultation in the context of the recommended pathway rather than as an isolated price-list line. Patients can ask for the follow-up structure as part of the written plan.

For procedural pathways where multi-session courses are clinically appropriate, the consultation arrives at the recommended session count and the structure for that case. The framework calibrates the pathway to what the case warrants rather than to a pre-bundled "package" that may exceed or fall short of the actual need. Where multi-session structures apply, the per-session figure and any bundle-level adjustment are surfaced clearly so the patient understands what is being paid for what.

Selected pathways allow session-by-session payment with the option to commit to an extended series after the early-response window has shown how the patient responds. The framework supports staged commitment in pathways where this fits the clinical calibration. Specific operational mechanics for the patient's pathway are agreed at the consultation; payment-structure details sit with the booking conversation rather than as a website-displayed offer.

The framework deliberately avoids time-limited "act-now" promotional pricing because it pushes patients toward decisions that the clinical calibration does not support. Selected continuity-of-care patterns may apply for established patients across long-term pathways; these are discussed in the context of the patient's case rather than as a generic discount layer. The framework does not run influencer-discount or price-led marketing campaigns.

The pricing framework is the same for all patients regardless of city of origin. For distance-restricted patients the framework can structure the visit and follow-up around fewer in-person trips with selected online review touch-points where clinical context permits, and the patient-side savings on travel and lodging are part of the planning conversation. The clinic pricing itself does not vary by patient origin.

Most cosmetic-dermatology procedural pathways are not covered by Indian health-insurance products; selected medical-dermatology contexts (severe acne under medical management, selected systemic-disease related dermatology contexts) may have insurance interaction depending on the patient's policy. The framework does not advise on insurance policy interpretation; the patient and their insurance provider are the right parties for that conversation. Selected payment-instrument financing options are operationally discussed at the booking conversation where relevant; the framework does not actively promote credit-driven booking.

The patient leaves the consultation with the written plan that includes the per-component pricing for the recommended pathway. The framework does not begin procedural work without that conversation having happened. Patients who want a formal cost discussion can ask for an itemised breakdown of the recommended pathway during the consultation; itemisation is part of the patient-facing transparency layer rather than an unusual request.

Calibration changes that affect cost are surfaced and discussed before they are billed. Where early-response review suggests adjusting session count, switching to a complementary pathway, or extending the maintenance pattern, the framework arrives at that recommendation in the follow-up conversation and the patient agrees the structure before it proceeds. The framework does not embed surprise charges within active pathways.

The Refund, Cancellation and Rescheduling Policy in the policies section covers the formal mechanics — notice windows, applicable conditions, and the route for handling specific cases. The framework treats reasonable cancellation and rescheduling as part of normal patient-flow rather than as penalty-driven friction. The formal policy text sits in the policies document.

The framework structures expectations through the consultation conversation, the written plan, and the follow-up review pattern, so the realistic outcome range is on the table from the start rather than discovered as a disappointment at the end. Where outcomes do not track the consented expectation the follow-up pathway covers calibration adjustment within the active framework. Where there is a formal concern the Complaints and Grievance Redressal Policy in the policies section is the route for handling. The framework distinguishes between calibration-stage adjustment (within the active pathway) and formal grievance handling.

Tax structure on dermatology services follows the prevailing regulatory framework. The figure quoted at the time of booking is the figure the patient pays at that booking, with applicable taxes handled per regulation. The framework does not invent or work around tax regulation; the booking conversation surfaces the tax-inclusive position so there is no surprise at billing time.